Cardiovascular Monitoring and Diagnostic Devices Market, By Product Type (ECG Monitoring Device, Holter Monitoring Device, ECG Stress Testing, Event Monitoring Devices), By End User (Hospital, Ambulatory Surgical Centers, Clinics), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI4021

Pages :150

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Cardiovascular Monitoring and Diagnostic Devices Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global cardiovascular monitoring and diagnostic devices market over the forecast period, owing to increasing research and developments of monitoring devices. For instance, on May 20, 2023, Abbott, a U.S.-based medical device company, announced results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess the dual-chamber leadless pacemaker, showing that the leadless pacemaker met its three pre-specified primary endpoints for safety and performance. The data further suggests that AVEIR DR could offer new benefits for people with slower-than-normal heart rhythms.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa